Mo Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mo Zhang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Dou Shi
Graduate School, Hebei North University, Zhangjiakou 075031, China
1 shared publication - Xianxian Wu
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), National Center of Technology Innovation for Animal Model, NHC Key Laboratory of Human Disease Comparative Medicine, National Human Diseases Animal Model Resource Center, Beijing, 100021, China
1 shared publication - Xing Liu
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical Collage (PUMC), Beijing 100021, China
1 shared publication - Yang Shi
Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China
1 shared publication - Yuhan Zhang
China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, No. 2 Yinghua Yuan East Street, Chaoyang District, Beijing 100029, China
1 shared publication - Zhiwei Yang
China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, No. 2 Yinghua Yuan East Street, Chaoyang District, Beijing 100029, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
The Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is the most common aortic disease occurring below the renal arteries, caused by multiple etiologies. Currently, no effective drug treatment exists, and the specific pathogenesis remains unclear. Due to its insidious onset and diagnostic challenges, AAA often culminates in aortic rupture, which has a high mortality rate. During AAA development, vascular smooth muscle cells (VSMCs) undergo significant pathological alterations, including contractile dysfunction, phenotypic modulation, cellular degradation, and heightened inflammatory and oxidative stress responses. In particular, emerging evidence implicates vascular smooth muscle cell (VSMC) metabolic dysregulation and mitochondrial dysfunction as key contributors to AAA progression. In this review, we systematically summarize the current understanding of VSMC biology, including their developmental origins, structural characteristics, and functional roles in aortic wall homeostasis, along with the regulatory networks governing the VSMC phenotype and functional maintenance. This review highlights the urgent need for further investigation into the aortic wall VSMC pathophysiology to identify novel therapeutic targets for AAA. These insights may pave the way for innovative treatment strategies in aortic disease management.
Top Cited PapersOpen AccessThe Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is the most common aortic disease occurring below the renal arteries, caused by multiple etiologies. Currently, no effective drug treatment exists, and the specific pathogenesis remains unclear. Due to its insidious onset and diagnostic challenges, AAA often culminates in aortic rupture, which has a high mortality rate. During AAA development, vascular smooth muscle cells (VSMCs) undergo significant pathological alterations, including contractile dysfunction, phenotypic modulation, cellular degradation, and heightened inflammatory and oxidative stress responses. In particular, emerging evidence implicates vascular smooth muscle cell (VSMC) metabolic dysregulation and mitochondrial dysfunction as key contributors to AAA progression. In this review, we systematically summarize the current understanding of VSMC biology, including their developmental origins, structural characteristics, and functional roles in aortic wall homeostasis, along with the regulatory networks governing the VSMC phenotype and functional maintenance. This review highlights the urgent need for further investigation into the aortic wall VSMC pathophysiology to identify novel therapeutic targets for AAA. These insights may pave the way for innovative treatment strategies in aortic disease management.